Clinical Trial Update: Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial assessing pegylated liposomal doxorubicin plus albumin-bound paclitaxel and trastuzumab in HER-2 positive breast cancer is ongoing, with statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Peking Union Medical College | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN